Beractant
- TRADE NAME: Survanta (AbbVie)
- INDICATIONS: Respiratory distress syndrome (RDS), hyaline membrane disease
- CLASS: Pulmonary surfactant
- HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
PREGNANCY CATEGORY: N/A
Please login to see the rest of this drug profile
CARDIOVASCULAR.
RESPIRATORY.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric